Primary results from the phase 3 ANDROMEDA study
Daratumumab is effective and safe
Refractory patients respond to combination therapy
New drugs, diagnostic tools are starting to revolutionize care
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Comprehensive treatment and trial access show promise